{
    "clinical_study": {
        "@rank": "134618", 
        "arm_group": [
            {
                "arm_group_label": "Real rTMS", 
                "arm_group_type": "Active Comparator", 
                "description": "The active group received Real rTMS over the hand area of motor cortex (20 Hz, 10 second, 10 trains with inter-train interval 30 second with total pulses 2000, intensity 80% of motor threshold) every day for ten consecutive days (5 days/week)."
            }, 
            {
                "arm_group_label": "Sham rTMS", 
                "arm_group_type": "Sham Comparator", 
                "description": "Sham-rTMS was applied using the same parameters but with the coil elevated and angled away from the head to reproduce the same of subjective sensation of rTMS"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study isto assess the efficacy of daily 10 sessions of rTMS over primary\n      motor cortex in patients suffering from malignant neuropathic pain. Thirty four patients\n      were divided randomly into 2 groups equally using closed envelops to undergo real (20 Hz, 10\n      second, 10 trains with inter-train interval 30 second with total pulses 2000, intensity 80%\n      of motor threshold over hand area of motor cortex) or sham rTMS (same parameters but with\n      coil elevated and angled away from the head)every day for ten consecutive days (5\n      days/week). Patients were evaluated using a verbal descriptor scale (VDS), visual analog\n      scale (VAS), Leeds assessment of neuropathic symptoms and signs (LANSS) and Hamilton rating\n      scale for depression (HAM-D) at baseline, after 1st, 5th, 10thtreatment session, and then 15\n      days and 1 month after the end of treatment. ic pain."
        }, 
        "brief_title": "rTMS as a Treatment of Neuropathic Pain Secondary to Malignancy", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "condition": "Malignancy", 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Neuralgia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        All patients within age group 18-65 years with malignant lateralized neuropathic pain\n        resistant to medical treatment for at least 2 months or associated with significant\n        adverse effects from medication were involved in this study.\n\n        Exclusion Criteria:\n\n        Patients with intracranial metallic devices Patients with pacemakers or any other device.\n        Patients with recent myocardial ischemia, unstable angina Patients  known to have history\n        of epilepsy."
            }, 
            "gender": "Both", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "34", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 1, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02078479", 
            "org_study_id": "rTMS with malignancy pain"
        }, 
        "intervention": [
            {
                "arm_group_label": "Real rTMS", 
                "intervention_name": "20 Hz, 10 s, 10 trains with inter-train interval 30 s 2000 pulses , intensity 80% over hand area daily for 10 consecutive days (5 days/week).", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Sham rTMS", 
                "intervention_name": "sham rTMS (same parameters but with coil elevated and angled away from the head)every day for ten consecutive days (5 days/week).", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Malignancy", 
            "VAS", 
            "LANSS", 
            "VDS", 
            "Neuropathic pain", 
            "rTMS", 
            "motor cortex", 
            "analgesia"
        ], 
        "lastchanged_date": "March 1, 2014", 
        "number_of_arms": "2", 
        "official_title": "Repetitive Transcranial Magnetic Stimulation in Neuropathic Pain Secondary to Malignancy.", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Egypt: Ministry of Higher Education", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Reduction of neuropathic pain in patients with malignancy measured by VDS, VAS, LANSS.", 
            "measure": "Neuropathic pain improvement", 
            "safety_issue": "No", 
            "time_frame": "one month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02078479"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Assiut University", 
            "investigator_full_name": "Eman M. Khedr", 
            "investigator_title": "Clinical Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Measurement of depression by using (HAM-D) scale.", 
            "measure": "Reduction of depression manifestation", 
            "safety_issue": "No", 
            "time_frame": "one month"
        }, 
        "source": "Assiut University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Assiut University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}